Analysis of paroxetine, fluoxetine and norfluoxetine in fish tissues using pressurized liquid extraction, mixed mode solid phase extraction cleanup and liquid chromatography-tandem mass spectrometry.
about
Cryptic confounding compounds: A brief consideration of the influences of anthropogenic contaminants on courtship and mating behaviorThe effects of antidepressants appear to be rapid and at environmentally relevant concentrations.Simultaneous determination of fluoxetine and its major active metabolite norfluoxetine in human plasma by LC-MS/MS using supported liquid extraction.Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone.Pharmaceuticals as neuroendocrine disruptors: lessons learned from fish on Prozac.Fluoxetine: juvenile pharmacokinetics in a nonhuman primate model.Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications.Profiling hepatic microRNAs in zebrafish: fluoxetine exposure mimics a fasting response that targets AMP-activated protein kinase (AMPK)Validation of mega composite sampling and nationwide mass inventories for 26 previously unmonitored contaminants in archived biosolids from the U.S National Biosolids Repository.Environmental concentrations of the selective serotonin reuptake inhibitor fluoxetine impact specific behaviors involved in reproduction, feeding and predator avoidance in the fish Pimephales promelas (fathead minnow).Profiling serotonin reuptake inhibitors (SSRIs) in the environment: trends in analytical methodologies.Ecotoxicological risk assessment and seasonal variation of some pharmaceuticals and personal care products in the sewage treatment plant and surface water bodies (lakes).Application of liquid chromatography-tandem mass spectrometry in quantitative bioanalyses of organic molecules in aquatic environment and organisms.Human therapeutic plasma levels of the selective serotonin reuptake inhibitor (SSRI) sertraline decrease serotonin reuptake transporter binding and shelter-seeking behavior in adult male fathead minnows.Photo-Fenton degradation of the pharmaceuticals ciprofloxacin and fluoxetine after anaerobic pre-treatment of hospital effluent.Uptake and depuration of pharmaceuticals in reclaimed water by mosquito fish (Gambusia holbrooki): a worst-case, multiple-exposure scenario.Analysis of selected pharmaceuticals in fish and the fresh water bodies directly affected by reclaimed water using liquid chromatography-tandem mass spectrometry.Comparative pharmaceutical metabolism by rainbow trout (Oncorhynchus mykiss) liver S9 fractions.The chemical fate of paroxetine metabolites. Dehydration of radicals derived from 4-(4-fluorophenyl)-3-(hydroxymethyl)piperidine.Pressurized liquid extraction followed by liquid chromatography with tandem mass spectrometry to determine pharmaceuticals in mussels.Pre-hatching fluoxetine-induced neurochemical, neurodevelopmental, and immunological changes in newly hatched cuttlefish.The determination of pharmaceutical residues in cooked and uncooked marine bivalves using pressurised liquid extraction, solid-phase extraction and liquid chromatography-tandem mass spectrometry.Bioaccumulation of pharmaceuticals and personal care product chemicals in fish exposed to wastewater effluent in an urban wetland.A review of the pharmaceutical exposome in aquatic fauna.Determination of Fluoxetine in Human Plasma by Liquid Chromatography–Mass Spectrometry and Its Application
P2860
Q30437406-61607D4A-9E50-47BE-B6AA-35D1FB82D71AQ30962448-C402BDAC-90FB-4C87-95FA-21F59184F42FQ33817132-F906442E-6138-4CDA-8ABA-34EE4A1E6B51Q34019354-24443035-DE12-4CD9-8225-692EE2429A45Q34203601-BD03B0CC-5C26-4788-9B2C-3F5A0C9653AEQ34250302-DFB2F419-5B13-42A5-8886-1E5F0FD339D6Q34296925-8C642A1C-5C49-4513-B822-B79975FEFF78Q35154001-AF103EB4-860B-4B8B-BBEB-DF6BAAFBE490Q36630551-00AA1FCA-6072-4C9D-8B00-B41D4A4871A8Q37706988-8296AE3B-9322-4BD7-865D-06283BBE85BDQ38267647-532BCC3C-1EFC-46D0-81A4-20C7FA9FA80DQ38629380-B35C4A24-99E0-44E8-94DC-FE3D72956EE6Q38782425-0DFF9D92-C0FC-4AD1-9BD1-B61B558B1AE8Q40018900-19829B68-949A-443C-9DF4-4F28BC8D31CAQ40397703-B174FF77-CBBD-4084-83FB-B3E79047559BQ43357702-A4521EAE-D2C1-42E8-B7B4-5D193BC9D14DQ44164382-91BDE665-9695-406D-9F4B-ADEE1A516A87Q44226726-DC6A6811-0417-4CAC-A88D-B97B56850E96Q44594481-276D0C47-4B08-4C8C-BFC2-85EF338DD5E5Q46627920-3FAC602C-628A-4B5A-9DD8-59B1AC070761Q46729759-53632B43-1C74-4514-A367-319390CD3F72Q46930542-BE53AD8F-2244-44BF-B17D-71942164B82CQ47153667-0FFDE083-CA91-41DE-AE44-B34D9BC4A18FQ53073985-B2DD39A8-8EAF-4553-B4A8-BE78E160A21CQ58135788-AD76F64D-A59C-4C69-8D3A-B5932C495AE6
P2860
Analysis of paroxetine, fluoxetine and norfluoxetine in fish tissues using pressurized liquid extraction, mixed mode solid phase extraction cleanup and liquid chromatography-tandem mass spectrometry.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Analysis of paroxetine, fluoxe ...... aphy-tandem mass spectrometry.
@ast
Analysis of paroxetine, fluoxe ...... aphy-tandem mass spectrometry.
@en
type
label
Analysis of paroxetine, fluoxe ...... aphy-tandem mass spectrometry.
@ast
Analysis of paroxetine, fluoxe ...... aphy-tandem mass spectrometry.
@en
prefLabel
Analysis of paroxetine, fluoxe ...... aphy-tandem mass spectrometry.
@ast
Analysis of paroxetine, fluoxe ...... aphy-tandem mass spectrometry.
@en
P1476
Analysis of paroxetine, fluoxe ...... aphy-tandem mass spectrometry.
@en
P2093
Chris D Metcalfe
Shaogang Chu
P304
P356
10.1016/J.CHROMA.2007.06.014
P407
P577
2007-06-13T00:00:00Z